Liquid biopsy: a step forward towards precision medicine in urologic malignancies

There is a growing trend towards exploring the use of a minimally invasive “liquid biopsy” to identify biomarkers in a number of cancers, including urologic malignancies. Multiple aspects can be assessed in circulating cell-free DNA, including cell-free DNA levels, integrity, methylation and mutatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Meo, Ashley, Bartlett, Jenni, Cheng, Yufeng, Pasic, Maria D., Yousef, George M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391592/
https://www.ncbi.nlm.nih.gov/pubmed/28410618
http://dx.doi.org/10.1186/s12943-017-0644-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391592/
https://www.ncbi.nlm.nih.gov/pubmed/28410618
http://dx.doi.org/10.1186/s12943-017-0644-5

Ejemplares similares